Comparison of Estonian and Finnish physicians' opinions of menopause and hormone therapy

Maturitas

Volumn 49, Issue 2, 2004, Pages 107-113

  Hovi, Sirpa Liisa ^a,b   Karttunen, Tiina ^a,b   Karro, Helle ^c   Hemminki, Elina ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

General practitioners; Gynaecologists; Hormone treatment; Menopause

Indexed keywords

HORMONE;

ARTICLE; BREAST CALCIFICATION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ESTONIA; FEMALE; FINLAND; GENERAL PRACTITIONER; GYNECOLOGY; HORMONE SUBSTITUTION; HUMAN; MALE; MEDICAL SPECIALIST; MENOPAUSE; PHYSICIAN; PRESCRIPTION; QUESTIONNAIRE; TREATMENT CONTRAINDICATION; UTERUS CANCER;

ESTONIA; ESTROGEN REPLACEMENT THERAPY; FAMILY PRACTICE; FEMALE; FINLAND; GYNECOLOGY; HUMANS; MALE; MENOPAUSE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PHYSICIANS, FAMILY; PHYSICIANS, WOMEN; QUESTIONNAIRES; SEX FACTORS;

EID: 4944229695     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.11.004     Document Type: Article

References (27)

1. Jolleys J.V., Olesen F. A comparative study of prescribing of hormone replacement therapy in USA and Europe. Maturitas. 23:1996;47-53
2. Topo P., Køster A., Holte A., Collins A., Landgren B.M., Hemminki E., et al. Trends in the use of climacteric and postclimacteric hormones in Nordic countries. Maturitas. 22:1995;89-95
3. Hemminki E., Topo P. Prescribing of hormone therapy in menopause and postmenopause. J Psychosom Obst Gyn. 18:1997;145-157
4. Topo P., Klaukka T., Hemminki E., Uutela A. Use of hormone replacement therapy in 1976-1989 by 45-64-year-old Finnish women. J Epidemiol Commun H. 45:1991;277-280
5. Helakorpi S, Patja K, Prättälä R, Uutela A. Health behaviour and health among Finnish adult population. Helsinki, Finland: Department of Epidemiology and Health Promotion. Health Promotion Research Unit. KTL - National Public Health Institute; 2001.
6. Topo P., Hemminki E., Uutela A. Women's choice and physicians' advice on use of menopausal and postmenopausal hormone therapy. Int J of Health Sci. 4:1993;101-109
7. Hemminki E, Karttunen T, Hovi S-L, Karro H. The drug industry and medical practice - the case of menopausal hormone therapy in Estonia. Soc Sci Med 2004;58:89-97.
8. Hemminki E., Topo P., Malin M., Kangas I. Physician's views on hormone therapy around and after menopause. Maturitas. 16:1993;163-173
9. Newton K.M., LaCroix A.Z., Buist D.S.M., Anderson L.A., Delaney K. What factors account for hormone replacement therapy prescribing frequence? Maturitas. 39(1):2001;1-10
10. Andersson K., Pedersen A.T., Mattsson L.A., Milsom I. Swedish gynaecologists' and general practitioners' views on the climacteric period: knowledge. Acta Obstet Gyn Scan. 77(9):1998;909-916
11. Nilsen ST, Pedersen AT, Moen MH, Milsom I, Mattsson LA, Iversen OE, et al. Knowledge, attitudes and management strategies in Scandinavia concerning hormone replacement therapy: a comparison between gynaecologists in Denmark, Norway and Sweden. Maturitas 2001;39(1):83-90.
12. Isaacs A.J., Britton A.R., McPherson K. Utilisation of hormone replacement therapy by women doctors. Brit Med J. 311:1995;1399-1401
13. Weiss S.R., Zuckerman I.H., Huang X., Hsu V.D. Clinical correlation of oestrogen replacement therapy use and duration of use among medicaid recipients. J Women Health Gen B. 10(8):2001;811-819
14. Wazana A. Physicians and the pharmaceutical industry. Is a gift ever just a gift. J Amer Med Assoc. 283:2000;373-380
15. Wyeth L. Kas naisgünekoloogit ise kasutavad hormoonasendusravi, ENS Teataja 2000;7:36-7.
16. Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Rosner B., Speizer F.E., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 325(11):1991;756-762
17. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 117(12):1992;1016-1037
18. Weiss N.S., Ure C.L., Ballard J.H. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of oestrogen. N Eng J Med. 303:1980;1195-1198
19. Ettinger B., Genant H.K., Cann C.E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 102(3):1985;319-324
20. Grady D., Wenger N.K., Herrington D., Khan S., Furberg C., Hunninghake D., et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. Ann Intern Med. 132(9):2000;689-696
21. Karro H., Veerus P., Laanpere M., et al. Hormoonasendusravi üleminekueas. Ravijuhiset Eestis. ENS Teataja. 8:2001;22-23
22. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy post-menopausal women. J Am Med Assoc 2002;288:321-33.
23. Beral V., Banks E., Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 360:2002;942-944
24. Barrett-Connor E., Stuenkel C.A. Hormone replacement therapy (HRT) - risks and benefits. Int J Epidemiol. 30:2001;423-426
25. Hays J., Ockene J.K., Brunner R.L., Kotchen J.M., Manson J.E., Patterson R.E., et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 348:2003;1839-1854
26. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 289:2003;2651-2662
27. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E. Efect of estrogen plus progestin in global cognitive function in postmenopausal women. The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 289:2003;2663-2672